SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors

    NEXT STORY
    Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients
    PREV STORY
    Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cyclacel Announces Abstracts Selected for Presentation at the American Association for Cancer Research Annual Meeting 2019

    author_avatar
    NASDAQ Market News

    GENFIT Announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASH

    author_avatar
    NASDAQ Market News

    ChemoCentryx Reports First Quarter 2018 Financial Results and Recent Highlights

    -- Patient enrollment in Phase III ADVOCATE trial of avacopan in the treatment of ...

    author_avatar
    NASDAQ Market News